Research ArticleArticle
Sleep Quality Is Related to Worsening Knee Pain in Those with Widespread Pain: The Multicenter Osteoarthritis Study
Zhaoli Dai, Tuhina Neogi, Carrie Brown, Michael Nevitt, Cora E. Lewis, James Torner and David T. Felson
The Journal of Rheumatology November 2019, jrheum.181365; DOI: https://doi.org/10.3899/jrheum.181365
Zhaoli Dai
From the Boston University School of Medicine, Department of Medicine, Section of Rheumatology, Boston, Massachusetts, USA; Epidemiology and Biostatistics, University of California, San Francisco, California; Department of Epidemiology, School of Public Health, University of Alabama at Birmingham, Birmingham, Alabama; Department of Epidemiology and the Institute for Clinical and Translational Science, The University of Iowa, Iowa, USA; The University of Sydney, Faculty of Medicine and Health, School of Pharmacy, Sydney, Australia; Centre for Epidemiology, University of Manchester and the National Institute for Health Research (NIHR) Manchester Biomedical Research Centre (BRC), Manchester University National Health Service (NHS) Trust, Manchester, UK. This study was supported by US National Institutes of Health grants: T32 AR7598 (Z. Dai), AR477785 and U01 AG18820 (D.T. Felson), U01 AG19069 (M. Nevitt), U01 AG18832 (J. Torner), U01 AG18947 (C.E. Lewis), and AR070892 (T. Neogi). Dr. Felson was also supported by the NIHR Manchester BRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Z. Dai, PhD, Boston University School of Medicine, Department of Medicine, Section of Rheumatology, and The University of Sydney, Faculty of Medicine and Health, School of Pharmacy; T. Neogi, MD, PhD, Boston University School of Medicine, Department of Medicine, Section of Rheumatology; C. Brown, MS, Boston University School of Medicine, Department of Medicine, Section of Rheumatology; M. Nevitt, PhD, Epidemiology and Biostatistics, University of California, San Francisco; C.E. Lewis, MD, Department of Epidemiology, School of Public Health, University of Alabama at Birmingham; J. Torner, MD, The Department of Epidemiology and the Institute for Clinical and Translational Science, The University of Iowa; D.T. Felson, MD, MPH, Boston University School of Medicine, Department of Medicine, Section of Rheumatology, and Centre for Epidemiology, University of Manchester and the NIHR Manchester BRC, Manchester University NHS Trust. Address correspondence to Z. Dai, D17, The Hub, 6th Floor, Charles Perkins Centre and School of Pharmacy, The University of Sydney, New South Wales 2006, Australia. E-mail: zhaoli.dai-keller@sydney.edu.au. Accepted for publication October 24, 2019.
Tuhina Neogi
From the Boston University School of Medicine, Department of Medicine, Section of Rheumatology, Boston, Massachusetts, USA; Epidemiology and Biostatistics, University of California, San Francisco, California; Department of Epidemiology, School of Public Health, University of Alabama at Birmingham, Birmingham, Alabama; Department of Epidemiology and the Institute for Clinical and Translational Science, The University of Iowa, Iowa, USA; The University of Sydney, Faculty of Medicine and Health, School of Pharmacy, Sydney, Australia; Centre for Epidemiology, University of Manchester and the National Institute for Health Research (NIHR) Manchester Biomedical Research Centre (BRC), Manchester University National Health Service (NHS) Trust, Manchester, UK. This study was supported by US National Institutes of Health grants: T32 AR7598 (Z. Dai), AR477785 and U01 AG18820 (D.T. Felson), U01 AG19069 (M. Nevitt), U01 AG18832 (J. Torner), U01 AG18947 (C.E. Lewis), and AR070892 (T. Neogi). Dr. Felson was also supported by the NIHR Manchester BRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Z. Dai, PhD, Boston University School of Medicine, Department of Medicine, Section of Rheumatology, and The University of Sydney, Faculty of Medicine and Health, School of Pharmacy; T. Neogi, MD, PhD, Boston University School of Medicine, Department of Medicine, Section of Rheumatology; C. Brown, MS, Boston University School of Medicine, Department of Medicine, Section of Rheumatology; M. Nevitt, PhD, Epidemiology and Biostatistics, University of California, San Francisco; C.E. Lewis, MD, Department of Epidemiology, School of Public Health, University of Alabama at Birmingham; J. Torner, MD, The Department of Epidemiology and the Institute for Clinical and Translational Science, The University of Iowa; D.T. Felson, MD, MPH, Boston University School of Medicine, Department of Medicine, Section of Rheumatology, and Centre for Epidemiology, University of Manchester and the NIHR Manchester BRC, Manchester University NHS Trust. Address correspondence to Z. Dai, D17, The Hub, 6th Floor, Charles Perkins Centre and School of Pharmacy, The University of Sydney, New South Wales 2006, Australia. E-mail: zhaoli.dai-keller@sydney.edu.au. Accepted for publication October 24, 2019.
Carrie Brown
From the Boston University School of Medicine, Department of Medicine, Section of Rheumatology, Boston, Massachusetts, USA; Epidemiology and Biostatistics, University of California, San Francisco, California; Department of Epidemiology, School of Public Health, University of Alabama at Birmingham, Birmingham, Alabama; Department of Epidemiology and the Institute for Clinical and Translational Science, The University of Iowa, Iowa, USA; The University of Sydney, Faculty of Medicine and Health, School of Pharmacy, Sydney, Australia; Centre for Epidemiology, University of Manchester and the National Institute for Health Research (NIHR) Manchester Biomedical Research Centre (BRC), Manchester University National Health Service (NHS) Trust, Manchester, UK. This study was supported by US National Institutes of Health grants: T32 AR7598 (Z. Dai), AR477785 and U01 AG18820 (D.T. Felson), U01 AG19069 (M. Nevitt), U01 AG18832 (J. Torner), U01 AG18947 (C.E. Lewis), and AR070892 (T. Neogi). Dr. Felson was also supported by the NIHR Manchester BRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Z. Dai, PhD, Boston University School of Medicine, Department of Medicine, Section of Rheumatology, and The University of Sydney, Faculty of Medicine and Health, School of Pharmacy; T. Neogi, MD, PhD, Boston University School of Medicine, Department of Medicine, Section of Rheumatology; C. Brown, MS, Boston University School of Medicine, Department of Medicine, Section of Rheumatology; M. Nevitt, PhD, Epidemiology and Biostatistics, University of California, San Francisco; C.E. Lewis, MD, Department of Epidemiology, School of Public Health, University of Alabama at Birmingham; J. Torner, MD, The Department of Epidemiology and the Institute for Clinical and Translational Science, The University of Iowa; D.T. Felson, MD, MPH, Boston University School of Medicine, Department of Medicine, Section of Rheumatology, and Centre for Epidemiology, University of Manchester and the NIHR Manchester BRC, Manchester University NHS Trust. Address correspondence to Z. Dai, D17, The Hub, 6th Floor, Charles Perkins Centre and School of Pharmacy, The University of Sydney, New South Wales 2006, Australia. E-mail: zhaoli.dai-keller@sydney.edu.au. Accepted for publication October 24, 2019.
Michael Nevitt
From the Boston University School of Medicine, Department of Medicine, Section of Rheumatology, Boston, Massachusetts, USA; Epidemiology and Biostatistics, University of California, San Francisco, California; Department of Epidemiology, School of Public Health, University of Alabama at Birmingham, Birmingham, Alabama; Department of Epidemiology and the Institute for Clinical and Translational Science, The University of Iowa, Iowa, USA; The University of Sydney, Faculty of Medicine and Health, School of Pharmacy, Sydney, Australia; Centre for Epidemiology, University of Manchester and the National Institute for Health Research (NIHR) Manchester Biomedical Research Centre (BRC), Manchester University National Health Service (NHS) Trust, Manchester, UK. This study was supported by US National Institutes of Health grants: T32 AR7598 (Z. Dai), AR477785 and U01 AG18820 (D.T. Felson), U01 AG19069 (M. Nevitt), U01 AG18832 (J. Torner), U01 AG18947 (C.E. Lewis), and AR070892 (T. Neogi). Dr. Felson was also supported by the NIHR Manchester BRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Z. Dai, PhD, Boston University School of Medicine, Department of Medicine, Section of Rheumatology, and The University of Sydney, Faculty of Medicine and Health, School of Pharmacy; T. Neogi, MD, PhD, Boston University School of Medicine, Department of Medicine, Section of Rheumatology; C. Brown, MS, Boston University School of Medicine, Department of Medicine, Section of Rheumatology; M. Nevitt, PhD, Epidemiology and Biostatistics, University of California, San Francisco; C.E. Lewis, MD, Department of Epidemiology, School of Public Health, University of Alabama at Birmingham; J. Torner, MD, The Department of Epidemiology and the Institute for Clinical and Translational Science, The University of Iowa; D.T. Felson, MD, MPH, Boston University School of Medicine, Department of Medicine, Section of Rheumatology, and Centre for Epidemiology, University of Manchester and the NIHR Manchester BRC, Manchester University NHS Trust. Address correspondence to Z. Dai, D17, The Hub, 6th Floor, Charles Perkins Centre and School of Pharmacy, The University of Sydney, New South Wales 2006, Australia. E-mail: zhaoli.dai-keller@sydney.edu.au. Accepted for publication October 24, 2019.
Cora E. Lewis
From the Boston University School of Medicine, Department of Medicine, Section of Rheumatology, Boston, Massachusetts, USA; Epidemiology and Biostatistics, University of California, San Francisco, California; Department of Epidemiology, School of Public Health, University of Alabama at Birmingham, Birmingham, Alabama; Department of Epidemiology and the Institute for Clinical and Translational Science, The University of Iowa, Iowa, USA; The University of Sydney, Faculty of Medicine and Health, School of Pharmacy, Sydney, Australia; Centre for Epidemiology, University of Manchester and the National Institute for Health Research (NIHR) Manchester Biomedical Research Centre (BRC), Manchester University National Health Service (NHS) Trust, Manchester, UK. This study was supported by US National Institutes of Health grants: T32 AR7598 (Z. Dai), AR477785 and U01 AG18820 (D.T. Felson), U01 AG19069 (M. Nevitt), U01 AG18832 (J. Torner), U01 AG18947 (C.E. Lewis), and AR070892 (T. Neogi). Dr. Felson was also supported by the NIHR Manchester BRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Z. Dai, PhD, Boston University School of Medicine, Department of Medicine, Section of Rheumatology, and The University of Sydney, Faculty of Medicine and Health, School of Pharmacy; T. Neogi, MD, PhD, Boston University School of Medicine, Department of Medicine, Section of Rheumatology; C. Brown, MS, Boston University School of Medicine, Department of Medicine, Section of Rheumatology; M. Nevitt, PhD, Epidemiology and Biostatistics, University of California, San Francisco; C.E. Lewis, MD, Department of Epidemiology, School of Public Health, University of Alabama at Birmingham; J. Torner, MD, The Department of Epidemiology and the Institute for Clinical and Translational Science, The University of Iowa; D.T. Felson, MD, MPH, Boston University School of Medicine, Department of Medicine, Section of Rheumatology, and Centre for Epidemiology, University of Manchester and the NIHR Manchester BRC, Manchester University NHS Trust. Address correspondence to Z. Dai, D17, The Hub, 6th Floor, Charles Perkins Centre and School of Pharmacy, The University of Sydney, New South Wales 2006, Australia. E-mail: zhaoli.dai-keller@sydney.edu.au. Accepted for publication October 24, 2019.
James Torner
From the Boston University School of Medicine, Department of Medicine, Section of Rheumatology, Boston, Massachusetts, USA; Epidemiology and Biostatistics, University of California, San Francisco, California; Department of Epidemiology, School of Public Health, University of Alabama at Birmingham, Birmingham, Alabama; Department of Epidemiology and the Institute for Clinical and Translational Science, The University of Iowa, Iowa, USA; The University of Sydney, Faculty of Medicine and Health, School of Pharmacy, Sydney, Australia; Centre for Epidemiology, University of Manchester and the National Institute for Health Research (NIHR) Manchester Biomedical Research Centre (BRC), Manchester University National Health Service (NHS) Trust, Manchester, UK. This study was supported by US National Institutes of Health grants: T32 AR7598 (Z. Dai), AR477785 and U01 AG18820 (D.T. Felson), U01 AG19069 (M. Nevitt), U01 AG18832 (J. Torner), U01 AG18947 (C.E. Lewis), and AR070892 (T. Neogi). Dr. Felson was also supported by the NIHR Manchester BRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Z. Dai, PhD, Boston University School of Medicine, Department of Medicine, Section of Rheumatology, and The University of Sydney, Faculty of Medicine and Health, School of Pharmacy; T. Neogi, MD, PhD, Boston University School of Medicine, Department of Medicine, Section of Rheumatology; C. Brown, MS, Boston University School of Medicine, Department of Medicine, Section of Rheumatology; M. Nevitt, PhD, Epidemiology and Biostatistics, University of California, San Francisco; C.E. Lewis, MD, Department of Epidemiology, School of Public Health, University of Alabama at Birmingham; J. Torner, MD, The Department of Epidemiology and the Institute for Clinical and Translational Science, The University of Iowa; D.T. Felson, MD, MPH, Boston University School of Medicine, Department of Medicine, Section of Rheumatology, and Centre for Epidemiology, University of Manchester and the NIHR Manchester BRC, Manchester University NHS Trust. Address correspondence to Z. Dai, D17, The Hub, 6th Floor, Charles Perkins Centre and School of Pharmacy, The University of Sydney, New South Wales 2006, Australia. E-mail: zhaoli.dai-keller@sydney.edu.au. Accepted for publication October 24, 2019.
David T. Felson
From the Boston University School of Medicine, Department of Medicine, Section of Rheumatology, Boston, Massachusetts, USA; Epidemiology and Biostatistics, University of California, San Francisco, California; Department of Epidemiology, School of Public Health, University of Alabama at Birmingham, Birmingham, Alabama; Department of Epidemiology and the Institute for Clinical and Translational Science, The University of Iowa, Iowa, USA; The University of Sydney, Faculty of Medicine and Health, School of Pharmacy, Sydney, Australia; Centre for Epidemiology, University of Manchester and the National Institute for Health Research (NIHR) Manchester Biomedical Research Centre (BRC), Manchester University National Health Service (NHS) Trust, Manchester, UK. This study was supported by US National Institutes of Health grants: T32 AR7598 (Z. Dai), AR477785 and U01 AG18820 (D.T. Felson), U01 AG19069 (M. Nevitt), U01 AG18832 (J. Torner), U01 AG18947 (C.E. Lewis), and AR070892 (T. Neogi). Dr. Felson was also supported by the NIHR Manchester BRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Z. Dai, PhD, Boston University School of Medicine, Department of Medicine, Section of Rheumatology, and The University of Sydney, Faculty of Medicine and Health, School of Pharmacy; T. Neogi, MD, PhD, Boston University School of Medicine, Department of Medicine, Section of Rheumatology; C. Brown, MS, Boston University School of Medicine, Department of Medicine, Section of Rheumatology; M. Nevitt, PhD, Epidemiology and Biostatistics, University of California, San Francisco; C.E. Lewis, MD, Department of Epidemiology, School of Public Health, University of Alabama at Birmingham; J. Torner, MD, The Department of Epidemiology and the Institute for Clinical and Translational Science, The University of Iowa; D.T. Felson, MD, MPH, Boston University School of Medicine, Department of Medicine, Section of Rheumatology, and Centre for Epidemiology, University of Manchester and the NIHR Manchester BRC, Manchester University NHS Trust. Address correspondence to Z. Dai, D17, The Hub, 6th Floor, Charles Perkins Centre and School of Pharmacy, The University of Sydney, New South Wales 2006, Australia. E-mail: zhaoli.dai-keller@sydney.edu.au. Accepted for publication October 24, 2019.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 3
1 Mar 2024
Sleep Quality Is Related to Worsening Knee Pain in Those with Widespread Pain: The Multicenter Osteoarthritis Study
Zhaoli Dai, Tuhina Neogi, Carrie Brown, Michael Nevitt, Cora E. Lewis, James Torner, David T. Felson
The Journal of Rheumatology Nov 2019, jrheum.181365; DOI: 10.3899/jrheum.181365